Geffner Michael — SEC Form 4 filings
SEC reporting owner CIK 2007249. 13 Form 4 filings on record with FilingPulse; latest filed 2025-10-24.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-01-29 to 2025-10-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 12 legs across 11 filings — 38,594 shares, $978,322 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 4.
- Largest priced transaction: sale of 9,948 shares @ $37.91 ($377,129) in Immunovant, Inc., filed 2024-01-29.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Immunovant, Inc. (IMVT) | Chief Medical Officer | 13 | — | 12 legs · 38,594 sh · $978,322 | 4 |
Form 4 filings — Geffner Michael
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-10-24 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 2,595 @ $19.03 | EDGAR |
| 2025-10-10 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 1,272 @ $16.30 | EDGAR |
| 2025-07-25 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 2,385 @ $18.15 | EDGAR |
| 2025-07-11 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 1,160 @ $17.24 | EDGAR |
| 2025-04-25 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 2,349 @ $14.79 | EDGAR |
| 2025-04-11 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 6,169 @ $12.99 | EDGAR |
| 2025-04-03 | 4 | Immunovant, Inc. (IMVT) | Grant/award (A): 101,574 @ $0 · Grant/award (A): 143,063 (derivative) @ $0 | EDGAR |
| 2025-01-24 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 2,657 @ $23.59 | EDGAR |
| 2024-10-25 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 3,189 @ $29.53 | EDGAR |
| 2024-07-26 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 3,456 @ $27.76 | EDGAR |
| 2024-04-26 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 3,261 @ $28.90 | EDGAR |
| 2024-04-04 | 4 | Immunovant, Inc. (IMVT) | Grant/award (A): 54,978 @ $0 · Grant/award (A): 68,723 (derivative) @ $0 | EDGAR |
| 2024-01-29 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 9,948 @ $37.91 · Sale (S): 153 @ $38.45 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2007249 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →